When prostate cancer returns after surgery, many men are treated with salvage radiotherapy (sRT). But before starting this treatment, it’s important to know exactly where the cancer has come back. A special scan called PSMA PET/CT is helping doctors do just that.
This study looked at real-world data from over 800 men in Denmark who had rising PSA levels after prostate surgery—a sign that the cancer might be back. Some of the men had a PSMA PET/CT scan before their radiotherapy. Others did not.
The results showed that those who had the scan lived longer. After five years, 98% of men who had the scan were still alive, compared to 94% of those who didn’t. The scan also helped more men stay free from another rise in PSA.
PSMA PET/CT can find cancer early—even when PSA levels are low. This helps doctors aim the radiotherapy more precisely, which may be why survival is better.
This study shows that having a PSMA PET/CT scan before treatment can make a real difference. It may help more men live longer and keep their cancer from returning.